Repetitive transcranial magnetic stimulation offers rapid depression relief for patients unresponsive to conventional ...
Mental health care is experiencing a breakthrough with Transcranial Magnetic Stimulation (TMS) therapy, a non-invasive and drug-free treatment providing hope for individuals battling depression, ...
BrainsWay Deep TMS is not currently cleared by the FDA for the safe or effective treatment of neuropathic pain. Additional outcomes from research conducted on these and other neuropathic pain patients ...
TMS Co., Ltd. (JP:4891) has released an update. TMS Co., Ltd. has announced the publication of Phase 2a clinical trial results for JX10 (TMS-007), a potential treatment for acute ischemic stroke ...
Sylvie Sallquist has struggled with severe depression and anxiety since she was a child, and this is her latest attempt to ...
BrainsWay (BWAY) announced the publication of positive feasibility clinical data evaluating the analgesic effects of deep transcranial magnetic ...
Looking to the future, we believe that mental health remains a key focus in the United States and the unmet demand for treatment remains at an all-time high. We continue to offer innovative ...
Neuronetics, Inc. (NASDAQ: STIM) has reported its financial and operational results for the third quarter of 2024, amid ...